Aethlon Medical (AEMD) Change in Account Payables (2011 - 2026)
Aethlon Medical's (AEMD) quarterly Change in Account Payables came in at -$169596.0 in Q1 2026, up 16.18% YoY from -$145976.7 in Q1 2025, and down 1498.76% quarter-over-quarter from -$10608.0 in Q4 2025.
Aethlon Medical (AEMD) Change in Account Payables (2011 - 2026) Analysis & Trends
Aethlon Medical's Change in Account Payables history runs 16 years deep, the most recent figure standing at -$169596.0 for Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables rose 16.18% year-over-year to -$169596.0; the trailing twelve-month figure through Mar 2026 stood at -$511315.0 (down 1643.31% YoY), and the FY2026 full-year result was -$511315.0, down 1643.31% from the prior year.
- Change in Account Payables was -$169596.0 for Q1 2026 at Aethlon Medical, down from -$10608.0 in the prior quarter.
- Over the last five years, Change in Account Payables for AEMD reached as high as $406264.0 in Q4 2023 and fell as low as -$229645.0 in Q4 2024.
- Median Change in Account Payables over the past 5 years was $6303.0 (2022), compared with a mean of -$3654.4.
- Across the five-year window, Change in Account Payables surged 3056.67% in 2023 and plunged 560.09% in 2024, its largest moves.
- Over 5 years, Change in Account Payables stood at $12870.0 in 2022, then surged by 3056.67% to $406264.0 in 2023, then sank by 156.53% to -$229645.0 in 2024, then surged by 95.38% to -$10608.0 in 2025, then tumbled by 1498.76% to -$169596.0 in 2026.
- Business Quant data shows AEMD's Change in Account Payables at -$169596.0 in Q1 2026, -$10608.0 in Q4 2025, and -$124144.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 56.90 Mn |
| 10 | Aethlon Medical | 3.70 Mn | -1.32 Mn | - | -169,596.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -169,596.00 |
| Mar 31, 2026 | -169,596.00 |
| Dec 31, 2025 | -10,608.00 |
| Dec 31, 2025 | -10,608.00 |
| Sep 30, 2025 | -124,144.00 |
| Sep 30, 2025 | -124,144.00 |
| Jun 30, 2025 | -206,967.00 |
| Jun 30, 2025 | -206,967.00 |
| Mar 31, 2025 | -202,334.00 |
| Mar 31, 2025 | -202,334.00 |
| Dec 31, 2024 | -229,645.00 |
| Dec 31, 2024 | -229,645.00 |
| Sep 30, 2024 | 279,026.00 |
| Sep 30, 2024 | 279,026.00 |
| Jun 30, 2024 | 186,084.00 |
| Jun 30, 2024 | 186,084.00 |
| Mar 31, 2024 | -109,611.00 |
| Mar 31, 2024 | -109,611.00 |
| Dec 31, 2023 | 406,264.00 |
| Dec 31, 2023 | 406,264.00 |